Carbapenem-resistant Enterobacterales in Children at 18 US Health Care System Study Sites: Clinical and Molecular Epidemiology From a Prospective Multicenter Cohort Study
Open Access
- 8 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (2) , ofad688
Abstract
Carbapenem-resistant Enterobacterales (CRE) are an urgent public health threat in the United States. Describe the clinical and molecular epidemiology of CRE in a multicenter pediatric cohort. CRACKLE-1 and CRACKLE-2 are prospective cohort studies with consecutive enrollment of hospitalized patients with CRE infection or colonization between December 24, 2011 and August 31 2017. Patients under 18 years and enrolled in the CRACKLE studies were included in this analysis. Clinical data were obtained from the electronic health record. Carbapenemase genes were detected using PCR and whole genome sequencing. 51 children were identified at 18 healthcare system study sites representing all U.S. census regions. The median age was 8 months, with 67% under 2 years. Median number of days from admission to culture collection was 11. Seventy-three percent of patients had required intensive care and 41% had a history of mechanical ventilation. Over half of children had no documented co-morbidities (Q1, Q3 0, 2). Sixty-seven percent previously received antibiotics during their hospitalization. The most common species isolated were Enterobacter species (41%), Klebsiella pneumoniae (27%), and Escherichia coli (20%). Carbapenemase genes were detected in 29% of isolates tested, which was lower than previously described in adults from this cohort (61%). Thirty-four patients were empirically treated on the date of culture collection, but only six received an antibiotic to which the CRE isolate was confirmed susceptible in vitro. Thirty-day mortality was 13.7%. CRE infection or colonization in U.S. children was geographically widespread, predominantly affected children under age 2 years, associated with significant mortality, and less commonly caused by carbapenemase-producing strains than in adults.Keywords
This publication has 20 references indexed in Scilit:
- The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin– and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric HospitalsJournal of the Pediatric Infectious Diseases Society, 2017
- Carbapenem-Resistant Enterobacteriaceae Infections in ChildrenCurrent Infectious Disease Reports, 2015
- Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999–2012Emerging Infectious Diseases, 2015
- Modeling Spread of KPC-Producing Bacteria in Long-Term Acute Care Hospitals in the Chicago Region, USAInfection Control & Hospital Epidemiology, 2015
- Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United StatesThe Pediatric Infectious Disease Journal, 2015
- A Five-Year Experience of Carbapenem Resistance in Enterobacteriaceae Causing Neonatal Septicaemia: Predominance of NDM-1PLOS ONE, 2014
- Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional NetworkAntimicrobial Agents and Chemotherapy, 2014
- Carbapenem-Resistant Enterobacteriaceae: An Emerging Problem in ChildrenClinical Infectious Diseases, 2012
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and PreventionClinical Infectious Diseases, 2011
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001